The collaborative drug discovery (CDD) database

Methods in Molecular Biology

Volumn 993, Issue , 2013, Pages 139-154

  Ekins, Sean ^a,b   Bunin, Barry A ^b  

^a Collaborations in Chemistry ^*  (United States)

^b Collaborative Drug Discovery ^*  (United States)

Author keywords

Collaborative Drug Discovery; Malaria; Neglected diseases; Tuberculosis

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DATA ANALYSIS SOFTWARE; DRUG DATABASE; DRUG RESEARCH; DRUG SCREENING; HEALTH CARE DELIVERY; PRIORITY JOURNAL; TECHNOLOGY; ANIMAL; COMPUTER PROGRAM; COOPERATION; DRUG DEVELOPMENT; DRUG EFFECT; HUMAN; INTERNET; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; ANTIMALARIALS; ANTITUBERCULAR AGENTS; COOPERATIVE BEHAVIOR; DATABASES, PHARMACEUTICAL; DRUG DISCOVERY; HUMANS; INTERNET; MYCOBACTERIUM TUBERCULOSIS; SOFTWARE;

EID: 84884226265     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-342-8_10     Document Type: Article

References (33)

1. Balganesh TS, Alzari PM, Cole ST (2008) Rising standards for tuberculosis drug development. Trends Pharmacol Sci 29:576-581
2. Payne DA et al (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Disc 6:29-40
3. Zhang Y (2005) The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 45:529-564
4. Carpy AJ, Marchand-Geneste N (2006) Structural e-bioinformatics and drug design. SAR QSAR Environ Res 17(1):1-10
5. Ertl P, Jelfs S (2007) Designing drugs on the internet? Free web tools and services supporting medicinal chemistry. Curr Top Med Chem 7(15):1491-1501
6. Munos B (2006) Can open-source R&D reinvigorate drug research? Nat Rev Drug Discov 5(9):723-729
7. Tralau-Stewart CJ et al (2009) Drug discovery: new models for industry-academic partnerships. Drug Discov Today 14(1-2):95-101
8. Williams AJ (2008) Internet-based tools for communication and collaboration in chemistry. Drug Discov Today 13(11-12):502-506
9. Williams AJ (2008) A perspective of publicly accessible/open-access chemistry databases. Drug Discov Today 13(11-12):495-501
10. Ekins S et al (2008) Molecular characterization of CYP2B6 substrates. Curr Drug Metab 9(5):363-373
11. Ekins S et al (2008) Computational discovery of novel low micromolar human pregnane X receptor antagonists. Mol Pharmacol 74:662-672
12. Nwaka S, Ridley RG (2003) Virtual drug discovery and development for neglected diseases through public-private partnerships. Nat Rev Drug Discov 2(11):919-928
13. Hohman M et al (2009) Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery. Drug Disc Today 14:261-270
14. Gamo F-J et al (2010) Thousands of chemical starting points for antimalarial lead identi fication. Nature 465:305-310
15. Ekins S, Williams AJ (2010) Meta-analysis of molecular property patterns and filtering of public datasets of antimalarial "hits" and drugs. Med Chem Comm 1:325-330
16. Ekins S, Williams AJ (2010) When pharmaceutical companies publish large datasets: an abundance of riches or fool's gold? Drug Disc Today 15:812-815
17. Ekins S et al (2010) Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis . Mol Biosyst 6:2316-2324
18. Metz JT, Huth JR, Hajduk PJ (2007) Enhancement of chemical rules for predicting compound reactivity towards protein thiol groups. J Comput Aided Mol Des 21(1-3):139-144
19. Huth JR et al (2005) ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. J Am Chem Soc 127(1):217-224
20. Lipinski CA et al (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 23:3-25
21. Oprea TI (2002) Current trends in lead discovery: are we looking for the appropriate properties? J Comput Aided Mol Des 16:325-334
22. Oprea TI et al (2001) Is there a difference between leads and drugs? A historical perspective. J Chem Inf Comput Sci 41:1308-1315
23. Rosen J et al (2009) Novel chemical space exploration via natural products. J Med Chem 52:1953-1962
24. Ekins S et al (2010) A collaborative database and computational models for tuberculosis drug discovery. Mol Biosyst 6:840-851
25. Guiguemde WA et al (2010) Chemical genetics of Plasmodium falciparum . Nature 465(7296):311-315
26. Gagaring, K., et al. Novartis-GNF malaria box. [cited]; Available from: ChEMBL-NTD (www. ebi.ac.uk/chemblntd)
27. Maddry JA et al (2009) Antituberculosis activity of the molecular libraries screening center network library. Tuberculosis (Edinb) 89:354-363
28. Ananthan S et al (2009) High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinb) 89:334-353
29. Ekins S, Freundlich JS (2011) Validating new tuberculosis computational models with public whole cell screening aerobic activity datasets. Pharm Res 28:1859-1869
30. Ekins S, Williams AJ (2010) Reaching out to collaborators: crowdsourcing for pharmaceutical research. Pharm Res 27(3):393-395
31. Williams AJ et al (2009) Free online resources enabling crowdsourced drug discovery. Drug Discov World 10:33-38
32. Louise-May S, Bunin B, Ekins S (2009) Towards integrated web-based tools in drug discovery. Touch Brief Drug Discov 6:17-21
33. Bingham A, Ekins S (2009) Competitive collaboration in the pharmaceutical and biotechnology industry. Drug Disc Today 14: 1079-1081